Answers
#1 in Business Subscribe Email Print

You are here: Home > Finance > Investing > Advanced Strategies - The Stock Replacement Covered Call Strategy

Tags

  • options
  • simultaneously
  • tackle
  • actual stock
  • actual stock
  • capital needed

  • Links

  • Best Gifts to Impress Single Women for Romance
  • Costa Maya: The Last Unexploited Coastal Paradise
  • Home Appeal for Today's Market
  • Answers - Advanced Strategies - The Stock Replacement Covered Call Strategy

    Recently, (October and November ‘03), the giant biotech Amgen
    (AMGN) came under some intense pressure, trading down about
    $12.00 before it found what appeared to be a decent level of
    support, and began to consolidate. At this level, anyone
    interested in going long Amgen at a discounted price would be
    advised to do so. Implied volatility was hi
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    gh coming off this
    precipitous drop, which caused premiums in the options to
    increase considerably.

    This scenario can be a very attractive for covered call sellers
    or buy-writers. On Tuesday, December 2, 2003, Amgen was trading
    at $58.90, the December 60 call was trading at $1.30, and there
    were only two weeks left until expiration.
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    br>
    Let’s assume that you wanted to take advantage of this
    opportunity but you would be unable to participate in it due to
    capital requirements. The stock was trading at $58.90 and you
    did not have sufficient funds to support buying the stock at
    that price. After all, the purchase of just 1000 shares would
    cost $58,900.00.

    Th
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    is is the time to consider using a strategy called stock
    replacement. In many instances, an insufficient amount of funds
    in the investors account can mean the loss of a golden
    opportunity when dealing with high dollar priced stocks.

    So, an alternative to purchasing the stock outright is to find a
    way to replace the actual stock with some
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    hing else which is not
    as expensive. In this case, a deep in-the-money call would do
    just that.

    When a call is deep in-the-money, meaning that the strike price
    of the call is much lower than the stock price, the delta of the
    call approaches 100. This means that there is close to a 100%
    chance that this option will finish in-the-mone
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    .

    Because of this, the option will trade just like the stock;
    penny for penny, dollar for dollar (in a theoretical 100 delta
    scenario.) If you recall, the term delta was mentioned when
    describing the option in question. Delta is the first derivative
    of the stock and it has a three pronged definition. The first is
    percentage change.<
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    br>
    The delta is given as a percentage change, meaning how much in
    percentage terms the option price will change with a movement in
    the stock. A 50 delta option will move 50% the amount the stock
    does. If the stock moves $1.00, than the option moves $.50. A 30
    delta option moves $.30 on a $1.00 movement in the stock, and so
    on.
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    Delta can also be defined as percent chance. This is used to
    describe the percentage chance that the option will end up
    in-the-money. A 90 delta option has a 90% chance of finishing
    in-the-money.

    Finally, delta can also be defined as hedge ratio which is the
    amount of deltas needed to properly hedge a position. These
    concepts will
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    be discussed in more detail in future Options
    University courses, but for now it is sufficient to just
    understand these basic concepts.

    It was important to explain the meaning of delta to understand
    that the deep in-the-money call would perform and act just like
    the stock. One way to determine if the call you will select is
    in-the-m
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    oney enough for your purpose is the delta. A delta in
    the mid or high 90’s is an ideal candidate.

    The selection of the proper in-the-money call to use is a
    critical element in the success of this strategy. In order to
    obtain an accurate delta of all options under consideration for
    stock replacement use, you can go to any number of web si
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    es or
    consult your broker. If all else fails, there is a little trick
    of the trade that can be used to aid in selecting a call that is
    deep enough in-the-money to suit the stock replacement criteria.

    To do this, check the quote of the corresponding put (i.e. the
    December 47.5 put if you are looking at the December 47.5 call
    for stoc
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    replacement). If there is no bid quoted for the put,
    then the call is deep enough in the money to consider it for a
    stock surrogate. There are several reasons for this being an
    effective strategy, which we wont cover here, but for the
    purposes of this discussion, it is enough to know that this
    method does work.

    So, with the stock a
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    t $58.90, the December 47.5 calls met the
    criteria for stock replacement. This call had a mid to high 90’s
    delta and its corresponding put had no bid. The December 47.5
    call was trading at $11.45 or $.05 over parity. By purchasing
    this option, you would be equivalently buying the stock at
    $58.95 (the strike price plus the option price).
    <
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    r> Let’s say that you bought the December 47.5 call for $11.45. If
    a total of 10 calls were purchased (an equivalent of 1000
    shares), you would lay out a total of $11,450 to fulfill your
    stock requirement on this buy-write. If you had purchased the
    stock outright, you would have spent $58,900. The difference
    between the capital needed to purc
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ase the stock outright
    ($58,900) and the capital needed to buy the in-the-money call
    ($11,450) is the key to this trade.

    Now that you have your stock (via the calls you bought above),
    it is time to sell covered calls against this position, which
    would be the December 60 calls for $1.30. If the stock stays at
    its present level, you w
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ould then capture the $1.30 premium that
    you sold the December 60 calls for because they finished
    out-of-the-money at expiration.

    The $1,300 profit in this scenario represents an 11.35% return
    in only two weeks. This well out-performs the return garnished
    on a $58,900 investment which would only be a 2.21% return in
    the two weeks, i
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    you purchased the actual stock.

    As we know, the maximum profit of $2.35 will be attained if the
    stock reaches $60.00 or above. This return comes from the $1.30
    you received in the premium for the sale of the now worthless
    December 60 call plus a $1.05 profit from the December 47.5 call
    you purchased. With the stock now at $60.00, the De
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ember 47.5
    call is worth parity, which is $12.50.

    You purchased the call for $11.45 thus you received a $1.05
    capital gain in the option. This profit of $2350.00 represents a
    20.5% return in two weeks verses a 3.98% return in two weeks, if
    you had purchased the actual stock.

    As you can see, you are getting the same overall dol
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    lar return
    on much less money - which creates a much higher percentage rate
    of return. This is one of the positive leverage effects that the
    proper usage of options can provide. When you initiate this
    trade, you are buying and selling two different options
    simultaneously which is known as a spread. A spread is a trade
    which involves the b
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ying of one option against the sale of a
    different option simultaneously and will be covered briefly in
    the next section.

    By buying the December 47.5 calls for $11.45 and then selling
    the December 60 calls at $1.30, you are buying the December 47.5
    December 60 call spread for $10.15. This type of spread is known
    as a vertical spread


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.answers.org.ua/article/103504/answers-Advanced-Strategies--The-Stock-Replacement-Covered-Call-Strategy.html">Advanced Strategies - The Stock Replacement Covered Call Strategy</a>

    BB link (for phorums):
    [url=http://www.answers.org.ua/article/103504/answers-Advanced-Strategies--The-Stock-Replacement-Covered-Call-Strategy.html]Advanced Strategies - The Stock Replacement Covered Call Strategy[/url]

    Related Articles:

    Parenting Your Employees to Better Performance

    Why Do They Buy?

    Why Should You Send E-Newsletters?

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com